Teza Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.32M | Sell |
16,941
-2,643
| -13% | -$207K | 0.99% | 7 |
|
2025
Q1 | $1.42M | Sell |
19,584
-71,252
| -78% | -$5.16M | 0.65% | 21 |
|
2024
Q4 | $6.72M | Buy |
90,836
+10,997
| +14% | +$814K | 1.02% | 11 |
|
2024
Q3 | $5.27M | Buy |
+79,839
| New | +$5.27M | 0.58% | 33 |
|
2024
Q2 | – | Sell |
-14,596
| Closed | -$1.39M | – | 636 |
|
2024
Q1 | $1.39M | Sell |
14,596
-4,257
| -23% | -$407K | 0.19% | 153 |
|
2023
Q4 | $1.44M | Sell |
18,853
-38,098
| -67% | -$2.9M | 0.24% | 134 |
|
2023
Q3 | $3.95M | Buy |
56,951
+53,999
| +1,829% | +$3.74M | 0.64% | 28 |
|
2023
Q2 | $278K | Sell |
2,952
-10,686
| -78% | -$1.01M | 0.05% | 426 |
|
2023
Q1 | $1.13M | Sell |
13,638
-1,095
| -7% | -$90.6K | 0.24% | 129 |
|
2022
Q4 | $1.1M | Buy |
+14,733
| New | +$1.1M | 0.21% | 151 |
|
2022
Q2 | – | Sell |
-4,800
| Closed | -$565K | – | 453 |
|
2022
Q1 | $565K | Sell |
4,800
-485
| -9% | -$57.1K | 0.21% | 146 |
|
2021
Q4 | $685K | Sell |
5,285
-1,526
| -22% | -$198K | 0.18% | 157 |
|
2021
Q3 | $771K | Sell |
6,811
-828
| -11% | -$93.7K | 0.37% | 79 |
|
2021
Q2 | $791K | Sell |
7,639
-1,299
| -15% | -$135K | 0.13% | 217 |
|
2021
Q1 | $748K | Buy |
+8,938
| New | +$748K | 0.15% | 199 |
|
2020
Q1 | – | Sell |
-8,976
| Closed | -$698K | – | 257 |
|
2019
Q4 | $698K | Buy |
+8,976
| New | +$698K | 0.19% | 170 |
|
2019
Q3 | – | Sell |
-5,919
| Closed | -$364K | – | 535 |
|
2019
Q2 | $364K | Buy |
5,919
+1,983
| +50% | +$122K | 0.21% | 172 |
|
2019
Q1 | $251K | Buy |
+3,936
| New | +$251K | 0.13% | 237 |
|
2018
Q3 | – | Sell |
-27,342
| Closed | -$1.33M | – | 428 |
|
2018
Q2 | $1.33M | Buy |
+27,342
| New | +$1.33M | 0.2% | 161 |
|
2017
Q2 | – | Sell |
-15,423
| Closed | -$484K | – | 140 |
|
2017
Q1 | $484K | Buy |
+15,423
| New | +$484K | 0.14% | 247 |
|